Lung Cancer Europe is delighted to welcome another new member to our Executive Team. Chiara Antoniani has been appointed LuCE’s […]
Follow Us
-
+1 700 888 1234
-
Effingerstrasse 40 3008 Bern Switzerland
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Lung Cancer Europe is delighted to welcome another new member to our Executive Team. Chiara Antoniani has been appointed LuCE’s […]
Ahead of the upcoming confirmation hearings for EU Health Commissioner-designate Olivér Várhelyi, LuCE wrote to members of the European Parliament […]
Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis: The majority of people impacted […]
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
